🇺🇸 FDA
Patent

US 8133904

Cannabinoid receptor antagonists/inverse agonists useful for treating obesity

granted A61PA61P1/16A61P3/00

Quick answer

US patent 8133904 (Cannabinoid receptor antagonists/inverse agonists useful for treating obesity) held by Jenrin Discovery, LLC expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Jenrin Discovery, LLC
Grant date
Tue Mar 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P1/16, A61P3/00, A61P3/04, A61P3/10